Previous studies showed that CD8+ T cells play a role in anti-tumor immunity (36, 37) and immune checkpoint inhibitors can be effective in the activation of CD8+ T cell responses and can restore anti-tumor immune responses (38). Here, CD8A is linked to neoplasm.